ストックスクリーナーアプリを入手
0.43
4.40%
-0.0198
前日終値:
$0.4498
開ける：
$0.442
24時間の取引高:
92,417
Relative Volume:
0.47
時価総額：
$7.35M
収益：
$4.03M
当期純損益:
$24.32M
株価収益率:
-0.10
EPS:
-4.3008
ネットキャッシュフロー:
$-45.76M
1週間 パフォーマンス:
-4.42%
1か月 パフォーマンス:
-28.73%
6か月 パフォーマンス:
-48.69%
1年 パフォーマンス:
-36.67%
1日の値動き範囲:
$0.43
$0.46
1週間の範囲:
$0.43
$0.48
52週間の値動き範囲:
$0.304
$1.90
Pavmed Inc Stock (PAVM) Company Profile
PAVM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.43 | 7.78M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
131.91 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.06 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
382.68 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.19 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.77 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
PAVmed Reports Q2 2025 Financial Results and Developments - MSN
PAVmed Q2 Earnings Miss Expectations; Market Reaction Remains Cautious - AInvest
Is PAVmed Inc. the Top Chart Pick This WeekWeekly Stock Report & AI Forecasted Entry and Exit Points - metal.it
PAVmed reports Q2 non-GAAP EPS (5c) vs. (84c) last year - MSN
PAVmed Reports Q2 2025 Financial Results: $13.3M Net Loss, $1.2M in Lucid Diagnostics Revenue - AInvest
PAVmed Q2 2025 slides reveal dramatic cost reduction amid Lucid Diagnostics growth By Investing.com - Investing.com South Africa
PAVmed Inc (PAVM) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
PAVmed 2025 Q2 Earnings Net Loss Narrows by 17.4% - AInvest
Lucid Diagnostics Advances Towards Medicare Coverage - MSN
PAVmed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
PAVmed Revenue Jumps 513% in Q2 - sharewise.com
PAVmed's EsoGuard Cancer Test Hits 2,756 Q2 Tests as Medicare Coverage Decision Nears - Stock Titan
PAVmed Inc. SEC 10-Q Report - TradingView
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - BioSpace
Lucid Diagnostics Reports Q2 2025 Financial Results - TipRanks
PAVmed's Q2 2025 Earnings Call: Unraveling Contradictions in Medicare Strategy, FDA Timelines, and Biopharma Expansion - AInvest
Transcript : PAVmed Inc., Lucid Diagnostics Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: Lucid Diagnostics highlights Q2 2025 growth and Medicare focus - Investing.com India
Lucid Diagnostics Inc: Navigating Earnings Challenges and Strategic Growth in a Competitive Diagnostics Landscape - AInvest
What makes PAVmed Inc. stock price move sharplyShort-Term Explosive Growth - thegnnews.com
PAVmed's Q2 2025 Earnings: A Strategic Inflection Point in Healthcare Innovation and Financial Turnaround - AInvest
PAVmed PAVM 2025Q2 Earnings Preview Upside Potential Driven by Strategic Innovations - AInvest
Investors Hope for Bounce in PAVmed Inc. After SelloffCapital Preservation Forecast Insight Signal - beatles.ru
Lucid Diagnostics to Participate in Upcoming Investor Conferences - Eastern Progress
Published on: 2025-08-05 15:46:56 - metal.it
Lucid Diagnostics to Participate in Upcoming Investor Conferences – Company Announcement - Financial Times
Cancer Prevention Leader Lucid Diagnostics Headlines Two Major Healthcare Investment Conferences This Month - Stock Titan
Trendline Breach Raises Concern for PAVmed Inc. InvestorsTriple Return Setup With Risk Control Explained - metal.it
PAVmed Inc. Forms Bullish Flag — Upside AheadEntry Plan for Oversold Reversal Stocks Released - metal.it
PAVmed Inc. Crosses 200 Day MA — Signal or NoiseReal-Time Analysis With Entry Targets In Progress - metal.it
Is PAVmed Inc. a growth stock or a value stockHigh-velocity gains - Jammu Links News
What are analysts’ price targets for PAVmed Inc. in the next 12 monthsUnlock exclusive stock analysis for investors - Jammu Links News
What analysts say about PAVmed Inc. stockUnlock powerful trading alerts for success - Jammu Links News
What are the latest earnings results for PAVmed Inc.Free Stock Selection - Jammu Links News
Does PAVmed Inc. stock perform well during market downturnsTrack high-yield stocks before they peak - Jammu Links News
When is PAVmed Inc. stock expected to show significant growthTremendous portfolio expansion - Jammu Links News
How strong is PAVmed Inc. company’s balance sheetCapitalize on emerging market sectors - Jammu Links News
What markets is BHST expanding into Is PAVmed Inc. stock a good long term investment option - Jammu Links News
PAVmed to Host Business Update Conference Call on August 14, 2025 - AInvest
Nasdaq Grants PAVmed 180-Day Extension to Meet Minimum Bid Price Rule - AInvest
Pavmed Inc. shares fall 1.22% after-hours following announcement of a business update conference call. - AInvest
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
PAVmed to Host Business Update Conference Call on August 14, 2025. - AInvest
PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan
Pattern recognition hints at PAVmed Inc. upsideCommunity Shared Smart Money Signals Show Movement - metal.it
Lucid Diagnostics to Host Business Update Conference Call and Webcast on August 13, 2025 - AInvest
Should I hold or sell PAVmed Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
0.07%
0.27%
大文字化:
|
ボリューム (24 時間):